Tamoxifen is effective in the treatment of Leishmania amazonensis infections in mice

PLoS Neglected Tropical Diseases

Volumn 2, Issue 6, 2008, Pages

  Miguel, Daniel C ^a   Yokoyama Yasunaka, Jenicer K U ^a   Uliana, Silvia R B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE; TAMOXIFEN CITRATE; ANTITRYPANOSOMAL AGENT; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DILUTION; DRUG EFFICACY; DRUG SENSITIVITY; LYMPH NODE; MOUSE; NONHUMAN; PARASITE IDENTIFICATION; QUANTITATIVE ANALYSIS; SKIN LEISHMANIASIS; SKIN ULCER; SPLEEN; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; FEMALE; LEISHMANIA; LEISHMANIASIS; PARASITOLOGY;

ANIMALS; FEMALE; LEISHMANIA; LEISHMANIASIS; MICE; MICE, INBRED BALB C; TAMOXIFEN; TRYPANOCIDAL AGENTS;

EID: 48949118061     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000249     Document Type: Article

References (20)

1. Berman JD, Chulay JD, Hendricks LD, Oster CN (1982) Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro. Am J Trop Med Hyg 31: 459-465.
2. Natera S, Machuca C, Padrón-Nieves K Romero A, Díaz E, et al. (2007) Leishmania spp.: proficiency of drug-resistant parasites. Int J Antimicrob Agents 29: 637-642.
3. Sundar S, Jha TY, Thakur CP, Engel J, Sindermann H, et al. (2002) Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 347: 1739-1746.
4. Soto J, Valda-Rodriquez L, Toledo J, Vera-Navarro, L, Luz M, et al. (2004) Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis. Am J Trop Med Hyg 71: 577-581.
5. Soto J, Berman J (2006) Treatment of New World cutaneous leishmaniasis with miltefosine. Trans R Soc Trop Med Hyg 100: 34-40.
6. Zerpa O, Ulrich M, Blanco B, Polegoe M, Avila A, et al. (2007) Diffuse cutaneous leishmaniasis responds to mittefosine but then relapses. Br J Dermatol 156: 1328-1335.
7. Soto J, Rea J, Balderrama M, Toledol J, Soto P, et al. (2008) Efficacy of miltefosine for Bolivian cutaneous leishmaniasis. Am J Tmp Med Hyg 78: 210-211.
8. Franke ED, Lucas CM, Tovar AA, Kruger JH, De Rivera MV, et al. (1990) Diffuse cutaneous leishmaniasis acquired in Peru. Am J Trop Med Hyg 43: 260-262.
9. Convit J, Ulich M, Fernández CT, Tapia FJ, Cáceres-Dittmar G, et al. (1993) The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 87:444-418.
10. Miguel DC, Yokoyama-Yasunaka JK, Andreoli WK, Mortara RA, Uliana SR (2007) Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes. J Antimicrob Chemother 60: 526-534.
11. Lima HC, Bleyenberg JA, Titus RG (1997) A simple method for quantifying Leishmania in tissues of infected animals. Parasitol Today 13: 80-82.
12. Barcinski MA, Schechtman D, Quintao LG, Costa Dde A, Soares LR, et al. (1992) Granolocyte-macrophage colony-stimulating factor increases the infectivity of Leishmania amazonensis by protecting promastigotes from heat-induced death. Infect Immun 60: 3523-3527.
13. Gonçalves; GS, Fernandes AP, Souza RC, Cardoso JE, de Oliveira-Silva F, et al. (2005) Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazononsis and Leishmania (Viannia) braziliensis. Acta Trop 93: 161-167.
14. Garnier T, Mäntylä A, Järvinen T, Lawrence J, Brown M, et al. (2007) In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs. J Antimicrob Chemother 60: 802-810.
15. Loo SA, Lesoon-Wood LA, Cooney RV (1998) Effects of tamoxifen on nitric oxide synthesis and neoplastic transformation in C3H 10T1/2 fibroblasts. Cancer Lett 122: 67-75.
16. Robinson SP, Langan-Fahey SM, Johnson DA, Jordan VC (1991) Metabolites, pharmacodynamics and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab Dispos 19: 36-43.
17. DeGregorio, MW, Wilbur BJ, Coronado E, Osborne CK (1987) Serum tamoxifen concentrations in the athymic nude mouse after three methods of administration. Cancer Chemother Pharmacol 20: 316-318.
18. Jordan VC (2007) New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer. Steroids 72: 829-842.
19. Perry MJ, Gujra S, Whitworth T, Tobias JH (2005) Tamoxifen stimulates cancellous bone formation in long bones of female mice. Endocrinology 146: 1060-1065.
20. Karimian E, Chagin AS, Gjerde J, Heino T, Lien EA, Ohlsson C, Sävendahl L (2008) Tamoxifen Impairs Both Longitudinal and Cortical Bone Growth in Young Male Rats. J Bone Miner Res. In press.